Lattice Semiconductor to Present at Jefferies 2019 Semiconductor, Hardware and Communications Infrastructure Summit
Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, announced that it is scheduled to host investor meetings at Jefferies 2019 Semiconductor, Hardware and Communications Infrastructure Summit on August 27, 2019 at the Ritz Carlton Chicago.
Jim Anderson, President and Chief Executive Officer, Sherri Luther, Chief Financial Officer, and Rick Muscha, Senior Director of Investor Relations, will meet with institutional investors to discuss Lattice Semiconductor's recent financial results, strategy and outlook.
About Lattice Semiconductor
Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing communications, computing, industrial, automotive and consumer markets. Our technology, long-standing relationships, and commitment to world-class support lets our customers quickly and easily unleash their innovation to create a smart, secure and connected world.
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...
OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, today announced its participation in the 'Runes Incubator.' This program, initiated by OnePiece Labs and supported by Merlin Chain and Franklin Templeton,...
SK hynix Inc. (or "the company", www.skhynix.com) announced today that it has recently signed a memorandum of understanding with TSMC for collaboration to...
ShipSaving, a fast-growing shipping platform recognized in the 2023 Deloitte Technology Fast 500tm, proudly announces a groundbreaking development as the first multi-carrier shipping company to offer UPS no-label shipping. This innovative feature...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...
In celebration of Miami Tech Month, the city of Miami is hosting a variety of events, welcoming venture capitalists, entrepreneurs, and technology innovators from around the globe. During this week, the city hosted Startup OLÉ, one of Europe's...
